MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 2 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,148,420 | -61.4% | 904,268 | 0.0% | 0.38% | -58.9% |
Q2 2023 | $2,975,042 | -20.0% | 904,268 | 0.0% | 0.93% | -37.8% |
Q1 2023 | $3,716,541 | -29.9% | 904,268 | 0.0% | 1.50% | -24.4% |
Q4 2022 | $5,299,010 | -13.3% | 904,268 | 0.0% | 1.98% | -10.5% |
Q3 2022 | $6,113,000 | +46.3% | 904,268 | 0.0% | 2.22% | +39.9% |
Q2 2022 | $4,178,000 | +15.8% | 904,268 | 0.0% | 1.58% | +43.2% |
Q1 2022 | $3,608,000 | – | 904,268 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |